Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UPDATE: Global device UDI comes a step closer amid manufacturer compliance concerns

This article was originally published in SRA

Executive Summary

The US Food and Drug Administration’s release in September 2013 of medical device unique identifier (UDI) and associated database guidance will promote patient safety and inject new pace into the move towards globally harmonized rules. That is the view of the FDA. While the device industry broadly agrees, the guidance has prompted certain concerns among medtech trade association AdvaMed and others, including about the ability of the SME-dominated industry to adapt with minimum burden. Ashley Yeo reports.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts